Project Grant R43EB033723
- This SBIR Phase I project, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on developing a groundbreaking architecture for thermal imaging lenses. The key objectives are to create smaller, lighter, and less expensive thermal imaging lenses using abundant semiconductor materials like silicon, while eliminating both image noise and chromatic aberration. This innovation aims to reduce the size and weight of...
- The National Science Foundation (NSF) awarded a $305,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to LR Innovoptics Inc. in Tucson, AZ. This SBIR Phase I project aims to develop a high-throughput 3D printing system for fabricating high-performance, high-contrast glass micro-optics. The goal is to create a faster, more scalable, and cost-effective manufacturing process for these critical optical components used in cameras, lasers, medical devices,...
- This $305,000 Small Business Innovation Research (SBIR) Phase I project, awarded by the National Science Foundation (NSF) through its Technology, Innovation, and Partnerships (CFDA 47.084) program, is developing innovative metasurface optical waveguiding devices (MOWGs) that control light on a sub-wavelength level. The goal is to overcome the limitations of traditional optical systems, such as weight, size, scalability, and cost, by replacing conventional optical components like lenses and...
- This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $416,925 to Objective Biotechnology, Inc. to develop and evaluate a miniature, high-performance microscope system for imaging brain activity in freely behaving mice. The award period runs from September 15, 2025 to August 31, 2027. The key objectives are to engineer the "Mini-MScope" device with a highly sensitive imaging sensor, evaluate its...
- This $546,494 award from the National Science Foundation's (NSF) Integrative Activities program (CFDA 47.083) will enable the University of California, Irvine (UCI) to acquire a high-resolution optical photothermal infrared (OPTIR) microscope system. This new microscope will support cutting-edge scientific research programs at UCI, foster collaborations with California State University Fullerton, and accelerate partnerships with industry. The OPTIR microscope will allow for sensitive,...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Small Business Innovation Research (SBIR) Phase I project award of $274,998 to Magnify Biosciences Inc. aims to develop an automated "AutoMagnify" device that physically expands biological specimens up to 1,000 times in 3D while preserving spatial and molecular integrity. This advancement will enable conventional light microscopes to achieve nanoscale imaging resolution capabilities...
- This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop and validate a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system tailored for high-resolution, wide-field retinal imaging in small animal models, specifically mice. The $305,000 project, awarded on September 1, 2025, with an expected completion date of August 31, 2026, has two key objectives: Develop and optimize a portable AO-OCT system with enhanced imaging capabilities...
- This STTR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on developing highly sensitive, room-temperature, single-photon detectors based on plasmonic metasurface coherent optical detection technology. The $304,987 award to Clearview Optics LLC aims to address the need for ultrasensitive optical detectors and ranging systems to enable improved information acquisition and perception...
- The National Science Foundation (NSF) awarded a Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Lensguide Imaging Technology Inc. for $275,000 to develop a nano-optical imaging microendoscope for in vivo imaging. The project aims to create a hair-sized, 100 μm diameter microendoscope that can image at depths greater than 3 mm in live animals with subcellular resolution, overcoming limitations of current optical imaging technologies. This...
- This federal Cooperative Agreement award from the National Institute of Standards and Technology (NIST) under the Science, Technology, Business and/or Education Outreach program (CFDA 11.620) provides $399,858.96 to Highri Optics, Inc. to develop a commercial product that will enable precise calibration of high-performance imaging systems and refine image processing to correct imperfections and reveal true images. The key products to be developed under this Phase II project include a calibration...
HIGH-RESOLUTION REFLECTIVE MICROSCOPE - THE GOAL OF THIS SBIR PROJECT IS TO DEVELOP AND COMMERCIALIZE A FUNDAMENTALLY NEW TYPE OF ALL-REFLECTIVE MICROSCOPE (ARM) WITHOUT ANY OBSCURATION FOR FULL SPECTRUM APPLICATIONS FROM ULTRAVIOLET (UV) TO INFRARED (IR). IN PHASE I STAGE, LIGHT RESEARCH INC (LRI) WILL DEMONSTRATE ARM BY DESIGNING, PROTOTYPING, AND CHARACTERIZING A HIGH NUMERICAL APERTURE (NA) REFLECTIVE OBJECTIVE AND TUBING LENS. CURRENT REFRACTIVE MICROSCOPE HAS A NUMBER OF LIMITATIONS DUE TO THE MATERIAL DISPERSION AND ABSORPTION: CHROMATIC ABERRATIONS, THROUGHPUT, GROUP DELAY DISPERSION (GDD), AND NARROW WORKING SPECTRAL RANGE. WHILE SUCCESSFULLY ADDRESSING THE LIMITATIONS ON CHROMATIC ABERRATION AND GROUP DELAY DISPERSION, THE TRADITIONAL SOLUTION - ON-AXIS REFLECTIVE OBJECTIVE - STILL HAS SOME OTHER MAJOR ISSUES DUE TO THE CENTRAL OBSCURATION, PREVENTING IT FROM BEING WIDELY ADOPTED IN BIOLOGICAL RESEARCH: LOW THROUGHPUT, LOW CONTRAST, AND LOW IMAGE QUALITY. TO ADDRESS ALL LIMITATIONS IN THE CURRENT STATE-OF-THE-ART REFRACTIVE AND REFLECTIVE MICROSCOPE, A FUNDAMENTALLY NEW AND TRUE ARM WITHOUT OBSCURATION WILL BE DEVELOPED. THE KEY INNOVATION OF THIS ARM IS THE OFF-AXIS CONFIGURATION WITH FREEFORM SURFACES. OFF-AXIS, NON-OBSCURATION OBJECTIVE WITH FREEFORM SURFACES WILL ADDRESS ALL ISSUES RELATED TO TRADITIONAL REFLECTIVE OBJECTIVE, AND HAS THE FOLLOWING UNIQUE KEY PROPERTIES: HIGH IMAGE CONTRAST, HIGH IMAGE QUALITY, HIGH LIGHT EFFICIENCY, HIGH THROUGHPUT, ZERO CHROMATIC ABERRATION, AND LOW GDD. LRI WILL LICENSE THE SNAP- ON ASSEMBLING TECHNOLOGY FROM UNIVERSITY OF ARIZONA (UA) TO DEVELOP AND COMMERCIALIZE THE ALIGNMENT-FREE OFF- AXIS, NON-OBSCURATION REFLECTIVE OBJECTIVE. THE GOAL OF THE PHASE I PROJECT WILL BE ACHIEVED THROUGH TWO AIMS: (1) DESIGN ARM, AND (2) PROTOTYPE AND CHARACTERIZE ARM. WITH THE GAINED KNOWLEDGE AND SUCCESSFUL DEMONSTRATION OF ARM IN PHASE I PROJECT, IN PHASE II LRI WILL DEVELOP AND COMMERCIALIZE A SERIES OF REFLECTIVE OBJECTIVES WITH DIFFERENT NAS AND TUBE LENSES WITH DIFFERENT FOCAL LENGTHS. WITH THE UNIQUE CAPABILITY OF HIGH-PERFORMANCE IMAGING FROM UV TO IR WITHOUT ANY OBSCURATION, THE TRUE ARM WILL NOT ONLY SIMPLIFY THE CONFIGURATIONS OF THE CURRENT MULTIMODAL AND BROADBAND IMAGING SYSTEMS, BUT ALSO ENABLE INVESTIGATORS TO ADVANCE THE BIOLOGICAL AND BIOMEDICAL RESEARCH THROUGH ACQUIRING NEW MULTIMODAL AND BROADBAND DATA WITH HIGHER THROUGHPUT AND SPEED IN FULL SPECTRUM, AND DEVELOPING NEW IMAGING TECHNIQUES NOT POSSIBLE WITH CURRENT MICROSCOPE PLATFORM.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/20/25 | ||
| Not listed | $259.2k | 7/19/22 | ||
| Not listed | $259.2k | 7/19/22 |